Company Profile:
At Verastem Oncology, we address urgent needs of patients living with cancers driven by RAS/MAPK pathway mutations, a key driver of tumor growth and treatment resistance. FDA approval of AVMAPKI FAKZYNJA CO-PACK delivered the first therapy for women living with recurrent KRAS-mutated low-grade serous ovarian cancer, a rare cancer with significant unmet need. We’ve launched this novel/novel combination therapy in the U.S. and are exploring pathways for Europe and Japan. We continue to advance our pipeline of drugs to help block cancer cell survival, inhibit tumor growth, and overcome treatment resistance. This is an exciting opportunity to shape the future of cancer care and make a meaningful impact in the lives of patients.
About The Role
Verastem Oncology has an exciting new opportunity to join our team as a Vice President, Commercial Strategy and New Product Planning. This role is responsible for defining the commercial strategy and new product plans in multiple therapeutic areas for VS-7375, a potential best in class KRAS G12D (ON/OFF) inhibitor and for future pipeline opportunities.
This role requires a strong blend of commercial and marketing experience, deep understanding of pharmaceutical product development and the ability to drive product strategy through thoughtful commercial analysis and market insights. The role will partner closely with all cross functional and R&D functions to provide unique insights to our development strategies and work closely with executive leadership as we communicate our pipeline vision. This individual must be a dynamic, self-starter who can work across the organization to translate scientific and clinical insights and align them with our patient-centric commercial goals.
Responsibilities:
Qualifications
Copyright © 2026 Grabjobs Pte.Ltd. All Rights Reserved.